We are thrilled to announce that our second publication has been accepted by the Journal of Biological Chemistry!
This work details the expression of Kv1.3 and its close homologs, which has been crucial in achieving best-in-class, extremely selective inhibitors. Our project aims to cure patients with autoimmune diseases through an immune-sparing mechanism of action.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
